Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2019 08:00 ET | Source: Hookipa Pharma Inc

HOOKIPA Pharma To Report Third Quarter 2019 Financial Results on November 12, 2019

NEW YORK and VIENNA, Austria, Nov. 04, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases...
October 31, 2019 08:15 ET | Source: Hookipa Pharma Inc

HOOKIPA Pharma to Present at Upcoming Conferences in November

NEW YORK and VIENNA, Austria, Oct. 31, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases...
September 25, 2019 08:30 ET | Source: Hookipa Pharma Inc

HOOKIPA Announces Key Hires to its Executive Team

Christine D. Baker has joined as Chief Business Officer Roman Necina, PhD, will join as Chief Technology Officer NEW YORK and VIENNA, Austria, Sept. 25, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma...
September 19, 2019 08:55 ET | Source: Hookipa Pharma Inc

HOOKIPA to Present Data Demonstrating the Potential of its TheraT® Technology at the Upcoming CICON Conference in Paris

NEW YORK and VIENNA, Austria, Sept. 19, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases...
August 29, 2019 08:30 ET | Source: Hookipa Pharma Inc

HOOKIPA Pharma to Present at Upcoming Investor Conferences in September

NEW YORK and VIENNA, Austria, Aug. 29, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases...
August 12, 2019 16:01 ET | Source: Hookipa Pharma Inc

HOOKIPA Pharma Reports Second Quarter 2019 Financial Results and Clinical Progress Highlights

NEW YORK and VIENNA, Austria, Aug. 12, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics, targeting infectious diseases...
July 11, 2019 16:01 ET | Source: Hookipa Pharma Inc

HOOKIPA Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers

New York and VIENNA, Austria, July 11, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers...
May 20, 2019 16:01 ET | Source: Hookipa Pharma Inc

HOOKIPA Pharma Reports First Quarter 2019 Financial Results and Recent Business Highlights

NEW YORK and VIENNA, Austria, May 20, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (“HOOKIPA”), a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers...
May 08, 2019 03:47 ET | Source: Hookipa Pharma Inc

HOOKIPA Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead

NEW YORK and VIENNA, Austria, May 08, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers...
April 25, 2019 08:30 ET | Source: Hookipa Pharma Inc

HOOKIPA Appoints David R. Kaufman to its Board of Directors

NEW YORK and VIENNA, Austria, April 25, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers...